Chemclin Diagnostics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	105.92	400.25	448.66	342.14	311.63
Trading Asset Securities	301.22	509	470	643	613
Cash & Short-Term Investments	407.14	909.25	918.66	985.14	924.63
Cash Growth	-55.22%	-1.02%	-6.75%	6.54%	67.08%
Accounts Receivable	12.93	20.31	25.29	34.06	35.13
Other Receivables	3.49	3.87	6.48	2.94	3.21
Receivables	16.42	24.18	31.77	37.01	38.34
Inventory	110.05	109.26	110.61	112.56	122.36
Other Current Assets	227.97	24.99	41.59	30.55	5.96
Total Current Assets	761.59	1,068	1,103	1,165	1,091
Property, Plant & Equipment	467.2	483.65	495.01	223.44	157.85
Goodwill	153.76	153.76	153.76	153.76	153.76
Other Intangible Assets	35.44	41.48	34.24	13.97	13.75
Long-Term Deferred Tax Assets	31.79	31.51	22.08	15.17	10.7
Long-Term Deferred Charges	48.73	54.08	12.84	19.59	3.55
Other Long-Term Assets	262.43	-	-	-	-
Total Assets	1,761	1,832	1,821	1,591	1,431
Accounts Payable	22.96	66.63	90.24	67.75	22.03
Accrued Expenses	8.6	17.99	22.22	38.88	24.13
Current Portion of Long-Term Debt	49.16	20.19	-	-	-
Current Portion of Leases	-	5.25	6.66	10.9	11.39
Current Income Taxes Payable	7.05	4.88	9.61	16.48	9.28
Current Unearned Revenue	13.06	9.6	6.91	4.58	3.57
Other Current Liabilities	58.71	58.81	58.5	58.67	51.16
Total Current Liabilities	159.54	183.35	194.13	197.25	121.56
Long-Term Debt	160.19	200.19	196.67	-	-
Long-Term Leases	22.62	24.12	31.28	1.57	13.22
Long-Term Unearned Revenue	2.75	-	-	-	5
Long-Term Deferred Tax Liabilities	4.95	8.18	9.68	11.77	12.46
Total Liabilities	350.05	415.85	431.76	210.59	152.23
Common Stock	401.11	401.11	401	401	401
Additional Paid-In Capital	565.66	565.66	564.92	564.92	547.48
Retained Earnings	495.22	500.63	422.88	414.65	330.2
Treasury Stock	-51.09	-51.09	-	-	-
Shareholders' Equity	1,411	1,416	1,389	1,381	1,279
Total Liabilities & Equity	1,761	1,832	1,821	1,591	1,431
Total Debt	231.97	249.76	234.61	12.47	24.6
Net Cash (Debt)	175.18	659.5	684.05	972.67	900.03
Net Cash Growth	-73.44%	-3.59%	-29.67%	8.07%	62.64%
Net Cash Per Share	0.44	1.66	1.72	2.42	2.33
Filing Date Shares Outstanding	349.94	394.59	401	401	401
Total Common Shares Outstanding	349.94	394.59	401	401	401
Working Capital	602.05	884.33	908.49	968	969.74
Book Value Per Share	4.03	3.59	3.46	3.44	3.19
Tangible Book Value	1,222	1,221	1,201	1,213	1,111
Tangible Book Value Per Share	3.49	3.09	2.99	3.02	2.77
Buildings	-	306.04	-	-	-
Machinery	-	446.91	391.37	381.13	383.66
Construction In Progress	-	0.58	365.61	103.13	7.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.